Bioceres Crop Solutions (NASDAQ:BIOX) Trading 2.1% Higher – What’s Next?

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) traded up 2.1% during mid-day trading on Monday . The company traded as high as $0.4499 and last traded at $0.4291. 259,426 shares changed hands during trading, a decline of 21% from the average session volume of 329,215 shares. The stock had previously closed at $0.4202.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Wall Street Zen downgraded Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a report on Saturday, April 4th. Weiss Ratings raised Bioceres Crop Solutions from a “sell (d-)” rating to a “sell (d)” rating in a report on Tuesday, May 26th. One equities research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Bioceres Crop Solutions has a consensus rating of “Hold” and a consensus target price of $4.00.

Bioceres Crop Solutions Price Performance

The company has a current ratio of 0.88, a quick ratio of 0.70 and a debt-to-equity ratio of 0.57. The firm has a market capitalization of $27.07 million, a PE ratio of -0.11 and a beta of 0.39. The company has a fifty day moving average price of $0.49 and a two-hundred day moving average price of $0.83.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its earnings results on Monday, May 11th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.11). Bioceres Crop Solutions had a negative net margin of 92.85% and a negative return on equity of 33.97%. The firm had revenue of $39.40 million during the quarter, compared to analysts’ expectations of $54.50 million. Sell-side analysts forecast that Bioceres Crop Solutions Corp. will post -0.16 earnings per share for the current year.

Institutional Trading of Bioceres Crop Solutions

Institutional investors and hedge funds have recently made changes to their positions in the company. GAM Holding AG acquired a new position in Bioceres Crop Solutions in the 4th quarter valued at about $655,000. Ardsley Advisory Partners LP increased its position in Bioceres Crop Solutions by 691.7% in the 4th quarter. Ardsley Advisory Partners LP now owns 475,000 shares of the company’s stock valued at $622,000 after acquiring an additional 415,000 shares during the period. Marshall Wace LLP increased its position in Bioceres Crop Solutions by 180.0% in the 4th quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock valued at $780,000 after acquiring an additional 382,744 shares during the period. Susquehanna International Group LLP acquired a new position in Bioceres Crop Solutions in the 3rd quarter valued at about $315,000. Finally, State of Wisconsin Investment Board acquired a new position in Bioceres Crop Solutions in the 4th quarter valued at about $247,000. 17.68% of the stock is owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.